| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Illumina's 23% post-earnings rally revives optimism across biotech ETFs as investors bet on a genomics rebound and ex-China...
Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related advers...
SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza ...
Enpro Inc. (NYSE: NPO) acquiring AlpHa Measurement Solutions and Overlook Industries for $280 million in cash.
Trump's comments on health-care negotiations with Democrats can put ETFs like XLV, IHF, and XHS back on investors' rada...
SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development and innovation.
Trump's policies have sparked a $350B investment surge in US biotech, creating job & revenue opportunities. Investors c...
Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial dist...